The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells

Journal of Cancer Research and Therapeutics

Volumn 11, Issue 1, 2015, Pages 18-23

  He, Zhonghui ^a   Hu, Beibei ^b   Tang, Lina ^b   Zheng, Shui'Er ^b   Sun, Yuanyu ^b   Sheng, Zan ^b   Yao, Yang ^b   Lin, Feng ^b  

^a Department of Nuclear Medicine   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Doxorubicin; MRP4; Osteosarcoma

Indexed keywords

DOXORUBICIN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; ABCC4 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CELL COUNTING; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MULTIDRUG RESISTANCE; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OSTEOSARCOMA; RNA, MESSENGER; TANDEM MASS SPECTROMETRY;

EID: 84928638214     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.143334     Document Type: Article

References (23)

1. Chou AJ and R Gorlick, Chemotherapy resistance in osteosarcoma: Current challenges and future directions. Expert Rev Anticancer Ther 2006. 6 (7): 1075-85.
2. Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L et al., Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 2005. 65 (18): 8142-50.
3. Gottesman MM and I Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993. 62: 385-427.
4. Germann UA, P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur J Cancer 1996. 32A (6): 927-44.
5. Loe DW, RG Deeley, and SP Cole, Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 1996. 32A (6): 945-57.
6. Chanteux H, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM. Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin. Antimicrob Agents Chemother 2005. 49 (4): 1279-88.
7. Ming X and DR Thakker, Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil. Biochem Pharmacol 2010. 79 (3): 455-62.
8. Eckford PD and FJ Sharom, ABC efflux pump-based resistance to chemotherapy drugs. Chem Rev 2009. 109 (7): 2989-3011.
9. Gillet JP, T Efferth and J Remacle, Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta 2007. 1775 (2): 237-62.
10. Lage H, An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 2008. 65 (20): 3145-67.
11. Mottino AD, Hoffman T, Jennes L and Vore M, Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther 2000. 293 (3): 717-23.
12. Nies AT, König J, Cui Y, Brom M, Spring H, Keppler D, Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). Eur J Biochem 2002. 269 (7): 1866-76.
13. Nies AT, Jedlitschky G, König J, Herold-Mende C, Steiner HH et al., Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004. 129 (2): 349-60.
14. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D, Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003. 38 (2): 374-84.
15. Marquez B and F Van Bambeke, ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr Drug Targets 2011. 12 (5): 600-20.
16. Dal Ben D, Palumbo M, Zagotto G, Capranico G, Moro S, DNA topoisomerase II structures and anthracycline activity: Insights into ternary complex formation. Curr Pharm Des 2007. 13 (27): 2766-80.
17. Borst P and RO Elferink, Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002. 71: 537-92.
18. Haimeur A, Conseil G, Deeley RG, Cole SP, The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004. 5 (1): 21-53.
19. Lee K, AJ Klein-Szanto and G.D Kruh, Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J Natl Cancer Inst 2000. 92 (23): 1934-40.
20. Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P et al., Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 2004. 24 (17): 7612-21.
21. Adachi M, Sampath J, Lan LB, Sun D, Hargrove P et al., Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem 2002. 277 (41): 38998-9004.
22. Lai L and TM Tan, Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J 2002. 361: 497-503.
23. Frederick CA, Williams LD, Ughetto G, van der Marel GA, van Boom JH et al., Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin. Biochemistry 1990. 29 (10): 2538-49.